Table 1.

NKR Surface Expression by CD56+ Cells Derived From CD34+ HPCs Cultured in FL for 21 Days, Followed By Culture in IL-15 for 14 Days

NKR NKR Subfamily % of NKR Expression in CD56+ Cells
Donor 1 Donor 2Donor 3 Mean ± SEM
CD158a  KIR2DL1/S1  0.59 1.14  0.56  0.76 ± 0.2  
CD158b  KIR2DL2/L3/S2 7.03  3.10  6.80  5.6 ± 1.0  
p70/CDw159 KIR3DL1/S1  0.88  0.37  0.04  0.43 ± 0.2  
p50.3 KIR2DS4  5.1  0.08  0.10  1.76 ± 1.7  
NKG2A C-type lectin  80.72  47.8  76.42 68.3 ± 8.4 
NKR NKR Subfamily % of NKR Expression in CD56+ Cells
Donor 1 Donor 2Donor 3 Mean ± SEM
CD158a  KIR2DL1/S1  0.59 1.14  0.56  0.76 ± 0.2  
CD158b  KIR2DL2/L3/S2 7.03  3.10  6.80  5.6 ± 1.0  
p70/CDw159 KIR3DL1/S1  0.88  0.37  0.04  0.43 ± 0.2  
p50.3 KIR2DS4  5.1  0.08  0.10  1.76 ± 1.7  
NKG2A C-type lectin  80.72  47.8  76.42 68.3 ± 8.4 

Purified CD34+ HPCs were cultured in FL (100 ng/mL) for 21 days, washed, and cultured in IL-15 (100 ng/mL) for an additional 14 days. Cells were harvested and stained with anti-NKR MoAbs and anti-CD56-PE as described in Materials and Methods. The flow cytometry dot-plot for donor 1 is shown in Fig 2C. No detectable NKR or CD56 expression was observed in the 3-week cultures before the addition of IL-15. Similar NKR profiles were obtained when KL (100 ng/mL) was substituted for FL in these experiments (not shown). Individual results from 3 donors, as well as the mean ± SEM, are shown.

or Create an Account

Close Modal
Close Modal